Spar Nord Bank A/S
Financial results for Q1 2025
Financial results for Q1 2025
Profit after tax of DKK 491 million and return on equity of 14.0%
With a profit after tax of DKK 491 million and a return on equity of 14.0%, Spar Nord is off to a good start to 2025. As expected, the result is affected by the falling level of interest rates, with a lower return on the Bank’s substantial excess liquidity contributing to a reduction in net interest income compared with last year. This is the principal reason why core income was DKK 136 million lower than in the same period of last year.
In terms of our banking business, we maintained a strong momentum from Q1 2024 to Q1 2025 with annual growth in lending and deposits of 10% and 6%, respectively, and a 4% increase in total business volume during the period. Looking exclusively at Q1 2025, lending was up by DKK 1.3 billion and deposits by DKK 0.7 billion.
The first quarter of 2025 was also characterised by further solid asset management activity, and activity in the housing market is once again trending higher. At the same time, impairment charges for the period were limited owing to persistently strong credit quality.
With respect to Nykredit’s takeover offer, two out of three conditions for the offer are currently met. The necessary approval from the Danish Competition and Consumer Authority remains outstanding and, most recently on 23 April 2025, this resulted in an extension of the offer period, which is now projected to expire on 20 May 2025. Nykredit still expects the offer to be completed during the first half of 2025, says Lasse Nyby, CEO.
Please direct any questions regarding this release to Lasse Nyby, Chief Executive Officer, on tel. +45 9634 4011, or Rune Brandt Børglum, Chief Financial Officer, on tel. + 45 9634 4236.
Yours faithfully
Rune Brandt Børglum
CFO
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Gabriel Holding A/S25.6.2025 07:36:50 CEST | Pressemeddelelse
Gabriel Holding A/S opjusterer forventningerne til regnskabsåret 2024/25 for de fortsættende aktiviteter
Gabriel Holding A/S25.6.2025 07:36:50 CEST | Press release
Gabriel Holding A/S upwardly adjusts its expectations for the financial year 2024/25 for the continuing operations
KH Group Oyj25.6.2025 07:30:25 CEST | Press release
KH Group: Indoor Group’s change negotiations concluded – profitability improvement measures continue
Idorsia Pharmaceuticals Ltd25.6.2025 07:20:00 CEST | Press release
Idorsia launches repurchase offer for its 2025 and 2028 convertible bonds
Sanofi Winthrop Industrie25.6.2025 07:00:00 CEST | Press release
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom